Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F38Y4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,578
Award facts
- Contract value 100% obligated
- $15,578.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,578.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections on December 30, 2025, with completion scheduled for December 31, 2025. This non-set-aside award represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 through December 2026. The product being delivered is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical supplies to federal healthcare systems.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the location of performance for this order—serves as a critical pharmaceutical distributor for military and veteran healthcare systems. The company holds significant federal contract authority to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order reflects the company's continued capability to meet federal procurement requirements through competitive award processes and demonstrates the operational flexibility of the DLA's pharmaceutical prime vendor model to support military medical readiness worldwide.
Quick answers
Who was awarded contract SPE2DR26F38Y4?
SPE2DR26F38Y4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F38Y4 worth?
The government has obligated $15,578 on SPE2DR26F38Y4.
Is contract SPE2DR26F38Y4 an order under another contract?
Yes. SPE2DR26F38Y4 is a delivery order under SPE2DR25D1051, an indefinite delivery contract.
Was contract SPE2DR26F38Y4 competed?
The extent of competition for SPE2DR26F38Y4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award